Promisia Healthcare Limited logo

Promisia Healthcare Interim Results

Half Year Results29 November 2021PHLHealthcare

1












































Unaudited Consolidated Interim Financial Statements


FOR THE SIX MONTHS ENDED 30 SEPTEMBER 2021


2










Promisia Healthcare Limited

(formally Promisia Integrative Limited)





Table of Contents


Consolidated Statement of Comprehensive Income ..................................................................................................... 3

Consolidated Statement of Changes in Equity ............................................................................................................... 4

Consolidated Balance Sheet ........................................................................................................................................... 5

Consolidated Statement of Cash Flows .......................................................................................................................... 6

Notes to the Consolidated Financial Statements ........................................................................................................... 7



3



Promisia Healthcare Limited

Consolidated Statement of Comprehensive Income

For the 6 months ended 30 September 2021



Unaudited Audited Unaudited


6 months

ended

15 months

ended

6 months

ended


30 September

2021

31 March

2021

30 June

2020


Notes $000 $000 $000


Revenue


8,766 6,060 56

Fair value movement of investment properties


- 1,250 -

Total Income


8,766 7,310 56

Administration expenses


(1,147)

(1,739) (707)

Operating expenses


(6,466) (4,555) (45)

Depreciation and amortisation expense


(433) (377) (3)

Finance costs


(837) (894) (34)

Total Expenses


(8,883) (7,565) (788)

Net gain/(loss) before income tax


(117) (255) (732)

Income tax credit


6 281 -

Net gain/( loss) for the period from continuing

operations


(111) 26 (732)


Discontinued operations


Profit/(Loss) for year after tax from discontinued

operations 4 19 30 -


Other comprehensive income


Items that may be later reclassified to profit or loss


Gain / (Loss) on translation of foreign currency


- (7) (2)

Total other comprehensive income


- (7) (2)

Total comprehensive income gain/(loss)


(92) 49 (734)


Earnings Per Share (dollars per share)


Basic & diluted earnings per share from continuing

operations 10 $(0.0005) $0.0004 $(0.03)

Basic & diluted earnings per share from discontinued

operations 10 $0.0001 $0.0004 $0.00









The accompanying notes form part of these financial statements


4



Promisia Healthcare Limited

Consolidated Statement of Changes in Equity

For the 6 months ended 30 September 2021




Issued Foreign Pooling of Accumulated Total


Capital Currency Interests Losses



Reserve Reserve



$000 $000 $000 $000 $000


6 months ended 30 June 2020 (unaudited)


Opening balance 58,526 183 - (60,063) (1,354)

Net loss for period - - - (732) (732)

Other comprehensive income / (loss) - (2) - - (2)

Closing balance at 30 June 2020 58,526 181 - (60,795) (2,088)



15 months ended 31 March 2021 (audited)


Opening balance 58,526 183 - (60,063) (1,354)

Net gain/(loss) for period - - - 56 56

Other comprehensive income / (loss) - (7) - - (7)

Pooling of interest reserve - - (717) - (717)

Share issue (Note 6)


18,869 - - - 18,869

Less share issue costs


(335) - - - (335)

Closing balance at 31 March 2021 77,060 176 (717) (60,007) 16,512



6 months ended 30 September 2021 (unaudited)


Opening balance


77,060 176 (717) (60,007) 16,512

Net gain/(loss) for period - - - (92) (92)

Share issue (Note 6)


235 - - - 239

Less share issue costs


(19) - - - (19)

Closing balance at 30 September 2021 77,276 176 (717) (60,099) 16,636






















The accompanying notes form part of these financial statements


5


Authorised on behalf of the Board

Wellington

25 November 2021

Stephen Underwood

Chairman

Tom Brankin

Director







Promisia Healthcare Limited

Consolidated Balance Sheet

As at 30 September 2021


Unaudited Restated (Note 3)


30 September 2021 31 March 2021


Notes $000 $000


Equity



Share capital 5 77,726 77,060

Accumulated losses


(60,099) (60,007)

Pooling of interest reserve


(717) (717)

Foreign currency translation reserve


176 176

Equity


16,636 16,512



Represented by:



Assets



Cash and cash equivalents


1,192 1,219

Trade and other receivables


1,334 1,765

Prepayments


191 249

Taxation receivable


- -

Related party advances


516 953

Property, plant & equipment 3 3,819 3,756

Right-of-use asset


8,951 9,285

Investment property


40,677 40,677

NZX deposit


20 20

Deferred taxation


302 303

Total assets


57,003 58,227


less



Liabilities



Trade and other payables


3,227 2,837

Taxation payable


197 472

Related party loans 3 - -

Interest bearing loans & borrowings


17,460 17,833

Lease liability


9,702 10,040

Occupancy rights agreements


9,781 10,533

Total liabilities


40,367 41,715

Net assets / (liabilities)


16,636 16,512









The accompanying notes form part of these financial statements


6



Promisia Healthcare Limited

Consolidated Statement of Cash Flows

For the 6 months ended 30 September 2021



Unaudited Audited Unaudited


6 months

ended

15 months

ended

6 months

ended


30 September

2021

31 March

2021

30 June

2020


Notes $000 $000 $000


Operating Activities


Receipts from residents for care fees and services


8,795 4,247 71

Receipts of residents' loans from new sales


3,981 1,590 -

Payments to suppliers and employees


(7,109) (4,314) (296)

Repayments of residents' loans


(4,388) (434) -

Interest paid


(837) (1,009) -

Income tax


(268) 444 -

Net operating cash flows from discontinued operations


19 42 -

Net operating cash flows


193 566 (225)


Investing activities


Acquisition of aged care assets


- (21,586) -

Purchase of property, plant & equipment


(162) (4,852) -

Net investing cash flows


(162) (26,438) -


Financing activities


Drawdown of loans


- 19,000 -

Repayment of related party advance 437 - -

Issue of share capital, net


216 8,665 -

Payments for lease liabilities


(338) (441) -

Repayment of borrowings


(373) (154) 215

Net cash flow from financing activities


(58) 27,070 215


Net increase / (decrease) in cash and cash equivalents


(27) 1,198 (10)


Cash and cash equivalents and beginning of period


1,219 21 21

Cash and cash equivalents at end of period


1,192 1,219 11







The accompanying notes form part of these financial statements


7


Promisia Healthcare Limited

Notes to and forming part of the Consolidated Financial Statements

For the 6 months ending 30 September 2021


1. Statement of compliance


The financial statements presented are those of Promisia Healthcare Limited (the Company) [formally Promisia

Integrative Limited], and its subsidiaries (the Group). Promisia Healthcare Limited is a profit-oriented entity

incorporated in New Zealand. Promisia Healthcare Limited’s principal activities are the ownership and operation of

retirement villages, rest homes, and hospitals for the elderly within New Zealand. The company formally developed

and marketed natural dietary supplements.


Promisia Healthcare Limited is a Financial Markets Conduct Act reporting entity under the Financial Reporting Act

2013 and the Financial Markets Conduct Act 2013.


The Company’s registered office is c/- Lay Associates, 66 High St, Leeston.


These financial statements have been approved for issue by the Board of Directors on 25 November 2021.


The financial statements been prepared in accordance with Generally Accepted Accounting Principles in New

Zealand (NZ GAAP). These are interim financial statements only.


2. Basis of preparation


Accounting policies are selected and applied to ensure the resulting financial information satisfies the concepts of

relevance and reliability, and the substance of the underlying transactions or other events is reported.


The financial statements are for the 6 months ended 30 September 2021.


The comparative figures are for the 15 months ended 31 March 2021 and the 6 months ended 30 June 2020. The

comparative figures to 30 June 2020 have limited relevance as the principal activities of the Group has transitioned

from developing and marketing research based natural dietary supplements, to the ownership and operation of

retirement villages, rest homes, and hospitals for the elderly within New Zealand. The comparative figures to 31

March 2021 include 5 months trading of the aged care facilities that were acquired on 30 October 2020.


The information is presented in New Zealand dollars, the Group’s functional and presentation currency and rounded

to the nearest thousand dollars unless stated otherwise.


There is no seasonality or cyclicality of the operations.


Measurement basis

These consolidated financial statements have been prepared on a historical-cost basis, as modified by the

revaluation of certain assets and liabilities, including investment properties, certain classes of property, plant and

equipment and right of use assets.

Critical judgements in applying accounting policies

In applying the groups accounting policies, management must make judgements, estimates, and assumptions. The

application of NZ IFRS also requires the use of certain critical accounting estimates.


The estimates and associated assumptions are based on historical experience and various other factors that are

reasonable under the circumstances. These estimates and assumptions concern projections of the future and will

seldom equal the related actual results.


8


The estimates and assumptions are reviewed and evaluated continuously. Revisions to accounting estimates are

recognised in the period in which the estimate is revised if the revision affects only that period.


Significant Accounting Policies

In accordance with NZ IAS 34 (16A) except and unless described below, the same accounting policies and methods of

computation are followed in the interim financial statements as those applied in the Group’s consolidated financial

statements for the 15 months ended 31 March 2021.


3. Restatement to Financial Statements


As part of the commissioning of the Aldwins House facility, Teltower Limited (the landlord and related party) funded

the build of a new kitchen and laundry to the value of $1m. This was initially to be by way of loan however, under

the Deed of Option Purchase Agreement it was agreed that the purchase price would be increased by an amount

equivalent to the cost of building the new kitchen and laundry up to a maximum value of $1m. The Deed of Option

to Purchase Agreement lapsed by mutual agreement on 9 August 2021. Neither the Agreement to Lease nor the

Deed of Option to Purchase Agreement provide repayment provisions for the $1m spent on the laundry/kitchen

redevelopment. The fit out of the new kitchen and laundry are the property of the landlord.


Following the lapse of the Deed of Option to Purchase Agreement, the company commissioned a further legal

review of the contract. Having considered the results of this legal review and the above facts, the Board considers

that the 31 March 2021 Balance Sheet representation of this transaction as a loan does not correctly reflect the

contractual position and accordingly requires restatement. NZ IAS 8 (Accounting policies, changes in accounting

estimates) requires retrospective correction of material prior period errors, except to the extent that it is

impracticable to determine either the period-specific effects or the cumulative effect of the error, and requires

disclosure of prior period errors.


The Board considers that it is appropriate to restate the Balance Sheet as at 31 March 2021. The impact of this

restatement is to reduce property, plant and equipment by $1m and reduce related party loans by $1m. An

adjustment to reduce associated depreciation expense by $0.08m has been recognised in the profit and loss for the

6 months ended 30 September 2021.


Restatements to 31 March 2021 Balance Sheet As Restated

(Note 3)

As previously

reported

31 March 2021 31 March 2021

$000 $000

Property, plant & equipment 3,756 4,756

Related party loans 0 1,000



4. Discontinued operations


The operation of developing and marketing natural dietary supplements ceased effective 19 December 2019. The

net operating profit (loss) after tax of the discontinued operation is reclassified within the statement of

comprehensive income and disclosed separately as are the comparative figures relating to the discontinued

operations.


5. Going concern


The Group has reported a net loss before tax from continuing operations of ($0.117m) for the six months ending 30

September 2021. The three fully operational facilities achieved a net profit before tax of $0.68m for the six months

ending 30 September 2021. However, the Aldwins House facility, which opened in December 2020 made a loss of

($0.83m). Discussions are continuing with the landlord of Aldwins House regarding the option to purchase the

building and/or lease terms.


9


On 31 August 2021, Promisia Healthcare Limited advised that the company had breached the EBITDA / Interest

banking covenant for the quarter ended 30 June 2021. On 28 October 2021, the company also advised that it had

breached the EBITDA / Interest banking covenant for the quarter ended 30 September 2021. The BNZ has advised

that it will not be taking any action at this time in respect of a breach for either the June or September quarters but

does reserve all of its rights with respect to the breaches.


In reviewing the June quarterly covenant reporting a breach of the Total Debt / Total Assets Covenant given by the

company was also discovered. The BNZ has provided a waiver of this covenant for the June quarter and removed

this covenant as an ongoing requirement for the company.


It is the continuing opinion of the board of directors that there are reasonable grounds to believe that its operational

and financial plans in place are achievable, and accordingly the Group is able to continue as a going concern and

meet its debts as and when they fall due. Accordingly, use of the going concern assumption remains appropriate in

these circumstances.


6. Share Capital

The Group’s share capital includes fully paid shares.

Issued and paid capital

There were 21,284,975,154 ordinary shares on issue at 30 September 2021 (15 months to 31 March 21:

21,021,209,451) (6 months to 30 June 2020: 2,151,797,451)

On 1

st

April 2021, 250,000,000 fully paid ordinary shares were issued at a price of $0.001 per share to wholesale

investors.

On 30

th

July 2021, Promisia completed the acquisition of shares held by persons with less than a minimum holding.

The total shares acquired were 51,518,410 at consideration of $95,874.36 of which $4,284.96 was donated to

KidsCan for shareholders who did not advise of a bank account and/or kindly donated their sale proceeds.

On 30

th

July 2021, 50,000,000 new shares were allotted at an issue price of $0.001 per share to wholesale investors.

On 30

th

July 2021, 15,285,000 new shares were allotted at an issue price of $0.002 per share in consideration for

services provided to Promisia.

Following these transactions total shareholder numbers reduced from 1,625 to 562.


Share Capital



6 months ended 15 months ended6 months ended

30 September 202131 March 202130 June 2020

shares 000shares 000 shares 000

Balance at beginning of financial period21,021,209 2,151,797 1,901,797

Shares issued (net)263,766 18,869,411 250,000

Balance at end of financial period21,284,975 21,021,209 2,151,797


10


7. Other financial information



8. Unaudited financial statements

The interim financial statements for the six months to 30 September 2021 have not been audited.


9. Related party transactions





i. Directors Fees are paid monthly to all Directors. On 12

th

August 2021, Duncan Priest resigned as a Director.

At 30 September 2021 no replacement has been appointed.


ii. No balances with related parties were written off or forgiven in the period.



6 months ended 15 months ended6 months ended

30 September 202131 March 202130 June 2020

$000$000$000

Net (Loss) Gain from continuing operations(111) 26 (732)

Included in the loss for the period are the following expenses:

6 months ended 15 months ended6 months ended

30 September 202131 March 202130 June 2020

Legal & Professional Fees190645309

NZX Listing & Regulatory Fees48253107

6 months ended 15 months ended6 months ended

30 September 202131 March 202130 June 2020

Notes$000$000$000

Transactions with related parties

Directors fees paid:T D Brankin25 21 26

S Underwood38 61 -

M D Priest9 21 12

H Down12 20 12

i84 123 50

Payments:

Lease payments to Teltower Ltd488 442 -

Interest paid to Brankin Family Interest Trust- 219 -

Funds advanced to Brankin Familiy Interest Trust- 1,085 -

Purchase of assets from Brankin Family Interest Trust- 31,385 -

Receipts:

Funds advanced by D Priest- 20 20

Funds advanced by Brankin Familiy Interest Trust437 1,000 195

New equity from Brankin Family Interest Trust- 8,000 -

30 September 202131 March 202130 June 2020

$000$000$000

Balances with related parties

Brankin Family Interest Trust - (receivable)(516) (953) -

Related party advance balances outstanding at end of period(516) (953) -


11


10. Earnings Per Share




The calculation of basic earnings per share is based on the loss from continuing operations attributable to ordinary

shareholders and the weighted average of total ordinary shares on issue during the year. The calculation of diluted

earnings per share is the same calculation as basic earnings per share as there were no share options to be

exercised.


11. Contingent liabilities


There are no contingent liabilities at the reporting date. (2021: $nil)


12. Key management personnel


On the 23

rd

August 2021, Chris Brown was appointed as the company’s new Chief Executive Officer. Chris brings a

broad range of experience from several different industries both in New Zealand and overseas. He has a proven

track record of growing businesses. An empathetic, strategic and operational business leader, he brings a strong skill

set to the business as we move through the next phase of our growth.


6 months ended 15 months ended6 months ended

30 September 202131 March 202130 June 2020

$000$000$000

Net Gain/(Loss) from continuing operations(111) 26 (732)

Cents per ShareCents per ShareCents per Share

Basic and diluted earnings per share(0.0005) 0.0004 (0.0377)

Number of

shares

Number of

shares

Number of

shares

000's000's000's

Weighted average number of shares for basic and diluted EPS21,219,568 7,077,555 1,941,523

---

Results announcement
(for Equity Security issuer/Equity and Debt Security issuer)




Results for announcement to the market

Name of issuer Promisia Healthcare Limited

Reporting Period 6 months to 30 September 2021

Previous Reporting Period 15 months to 31 March 2021

Currency

Amount (000s) Percentage change

Revenue from continuing

operations

$8,766 44.6%

Total Revenue $8,766 19.9%

Net profit/(loss) from continuing

operations

-$111 -525.6%

Total net profit/(loss) -$92 -286.2%

Interim/Final Dividend

Amount per Quoted Equity

Security

No dividend is proposed

Imputed amount per Quoted

Equity Security

Not applicable

Record Date Not applicable

Dividend Payment Date Not applicable

Current period Prior comparable period

Net tangible assets per Quoted

Equity Security

$0.0008 $0.0008

A brief explanation of any of the

figures above necessary to

enable the figures to be

understood

A revaluation of the investment properties has not been undertaken for

the interim results and as a result revenue from continuing operations

is the same as total revenue for the interim results.

The interim results include 6 months of trading as an aged care

provider. The prior period included 5 months of trading as an aged care

provider.

Authority for this announcement

Name of person


authorised to

make this announcement

Stephen Underwood, Chairman

Contact person for this

announcement

Chris Brown, Chief Executive Officer

Contact phone number 021379153

Contact email address chris.brown@promisia.co.nz

Date of release through MAP


29/11/2021


Unaudited financial statements accompany this announcement.

---

Market Announcement
29 November 2021

PROMISIA HEALTHCARE INTERIM RESULTS

For the six months ended 30 September 2021

Aged care provider, Promisia Healthcare Limited (NZX: PHL) has reported its unaudited results for

the six months to 30 September 2021.

The company commenced operation as an aged care business in October 2020. The prior

comparative period of the 15 months to 31 March 2021 reflects 5 months of trading as an aged care

provider. The 6 months to 30 June 2020 reflects discontinued operations only.

Promisia has a diversified growth strategy focused on facility development, broadening its revenue

mix and acquisition of further aged care and retirement village facilities, particularly in provincial

areas.

The company currently has a portfolio of four aged care facilities (three owned and one leased),

focused on rest home and hospital services, including high needs and specialised aged care. During

the recent COVID lockdowns and restrictions, the priority has been on delivering quality care and

ensuring the safety of residents, particularly given the higher care needs of many residents. All on-

site staff are fully vaccinated and robust health and safety protocols are in place.

During the six month period, the company’s leadership team was strengthened with the

appointment of Chris Brown as CEO from 23 August 2021 and Angie Mehlhopt as the group’s

Financial Accountant in July 2021. The new executive team is focused on integrating and establishing

systems across the group and executing Promisia’s growth strategy.

Good progress has been made on the development at Ranfurly Manor in Fielding which comprises

32 villas and 10 care suites. The care suites are due to be completed in the next two weeks and sales

and marketing of these suites is now underway. Eight villas have been sold. The first four villas are

expected to be ready for occupancy at the end of January 2022, a further four villas are currently

under construction with another four about to commence.

Construction is being carried out at no capital cost to PHL, with the purchase price to be paid to the

developer (Colspec) from proceeds of the initial sale of an ORA for each new villa or care suite.

Rooms are also being opened progressively at Promisia’s newest facility, Aldwins House in

Christchurch, as demand grows which is currently at a slower rate than anticipated. New

management and clinical teams have been put in place and a range of opportunities are being

investigated to grow demand and minimise outgoings. Discussions with the landlord to acquire the

building are ongoing. Occupancy levels at Promisia’s other facilities remain strong.

CEO of Promisia, Chris Brown, said: “The team has done an outstanding job during yet another

challenging period, as we focused on keeping our residents well cared for and safe during the latest

COVID restrictions. Our immediate focus is on growing occupancy and revenue at our existing

facilities, particularly Aldwins House, and building our systems infrastructure to support growth. The


development at Ranfurly Manor is progressing well and we are looking forward to welcoming new

residents into these care suites and villas in the next few months.”

Chair of Promisia, Stephen Underwood, said: “It is a year since the successful acquisition of the aged

care business. This acquisition has enabled us breathe new life into Promisia and provide a good

platform for growth.

The aged care sector is projected to grow strongly over the next ten years, particularly for higher

needs and specialised care. Provincial communities are often under-resourced in terms of aged care.

Promisia is a valued part of the communities where it is located and provincial New Zealand will

remain a focus for us. Acquisitions continue to be considered based on quality, geographic and

cultural fit, demand for services, growth potential and contribution to profitability. We are pleased

to have a new leadership team in place and we are building our business to capitalise on long term

demand.”

Financial Performance

Revenue for the six months was $8.8m and is expected to grow as occupancy levels (particularly at

Aldwins House) and ORA sales increase. The company reported a net loss from continuing

operations of $111,000, with a total loss from continuing and discontinuing operations of $92,000.

As at 30 September 2021, total assets were $57.0m, net debt was $17.5m and the company had

cash and cash equivalents of $1.2m.

As disclosed previously, during the period Promisia concluded a constructive dialogue with its

banking partner, BNZ, regarding its banking covenants. The BNZ advised that no actions would be

taken in respect of the EBITDA / Interest covenant breaches in the June and September 2021

quarters (although BNZ reserves all of its rights with respect to the breaches); and has provided a

waiver and removed the Total Debt / Total Assets covenant as an ongoing requirement.

ENDS

For more information, please contact:

Chris Brown, CEO on +64 21 379 153 or email chris.brown@promisia.co.nz

For media assistance, please contact: Jackie Ellis on +64 27 246 2505 or email

jackie@ellisandco.co.nz.

About Promisia Healthcare

Promisia operates four aged care facilities, specialising in high needs and specialised aged care

(being rest home, hospital and dementia care). It also offers independent living in retirement villas

and care suites. Promisia’s facilities are located in well-established and well serviced towns with

strong communities and close to main centres. The company has a diversified growth strategy that

includes growing its portfolio, developing existing facilities and extending its revenue mix.

Promisia is listed on the NZX (NZX: PHL). www.promisia.co.nz

Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.

Other issuers discussed similar conditions around this time

Matched by meaning across NZX announcement text, not keywords — based on our semantic index of announcement bodies.